A detailed history of North Rock Partners, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, North Rock Partners, LLC holds 3,511 shares of ZTS stock, worth $620,534. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,511
Previous 5,553 36.77%
Holding current value
$620,534
Previous $962,000 28.79%
% of portfolio
0.06%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$172.58 - $196.48 $352,408 - $401,212
-2,042 Reduced 36.77%
3,511 $685,000
Q2 2024

Aug 06, 2024

SELL
$145.54 - $178.83 $16,737 - $20,565
-115 Reduced 2.03%
5,553 $962,000
Q1 2024

May 07, 2024

BUY
$165.67 - $199.94 $250,658 - $302,509
1,513 Added 36.41%
5,668 $959,000
Q4 2023

Feb 08, 2024

BUY
$151.44 - $200.09 $64,513 - $85,238
426 Added 11.42%
4,155 $820,000
Q3 2023

Oct 24, 2023

BUY
$167.14 - $192.77 $23,901 - $27,566
143 Added 3.99%
3,729 $648,000
Q2 2023

Aug 02, 2023

SELL
$160.94 - $186.23 $9,173 - $10,615
-57 Reduced 1.56%
3,586 $617,000
Q1 2023

May 03, 2023

BUY
$145.48 - $175.02 $94,416 - $113,587
649 Added 21.68%
3,643 $606,000
Q4 2022

Feb 01, 2023

SELL
$131.14 - $157.47 $35,407 - $42,516
-270 Reduced 8.27%
2,994 $438,000
Q3 2022

Nov 02, 2022

SELL
$148.29 - $182.55 $29,658 - $36,510
-200 Reduced 5.77%
3,264 $484,000
Q2 2022

Aug 04, 2022

BUY
$155.97 - $200.09 $49,754 - $63,828
319 Added 10.14%
3,464 $595,000
Q1 2022

May 05, 2022

SELL
$181.39 - $234.03 $41,175 - $53,124
-227 Reduced 6.73%
3,145 $593,000
Q4 2021

Feb 07, 2022

BUY
$193.69 - $247.03 $337,795 - $430,820
1,744 Added 107.13%
3,372 $823,000
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $88,019 - $97,505
465 Added 39.98%
1,628 $316,000
Q2 2021

Aug 12, 2021

BUY
$155.9 - $187.99 $181,311 - $218,632
1,163 New
1,163 $217,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track North Rock Partners, LLC Portfolio

Follow North Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.